Resar L, Luo L
Int J Mol Sci. 2025; 26(5).
PMID: 40076747
PMC: 11899949.
DOI: 10.3390/ijms26052125.
Su L, Deng Z, Santos-Fernandez M, Jeanne Dit Fouque K, Chapagain P, Chambers J
Nucleic Acids Res. 2025; 53(3).
PMID: 39873271
PMC: 11773362.
DOI: 10.1093/nar/gkaf035.
Handa S, Schaniel C, Tripodi J, Ahire D, Mia M, Klingborg S
Leukemia. 2024; 39(3):663-674.
PMID: 39715853
PMC: 11879852.
DOI: 10.1038/s41375-024-02496-0.
Raza F, Monawwer S, Husnain M, Golubeva D, Fatima L, Haque M
Clin Case Rep. 2024; 12(12):e9664.
PMID: 39619307
PMC: 11606927.
DOI: 10.1002/ccr3.9664.
Lim C, Seo D
Sci Rep. 2024; 14(1):23981.
PMID: 39402095
PMC: 11473660.
DOI: 10.1038/s41598-024-75491-1.
Binding to the Other Side: The AT-Hook DNA-Binding Domain Allows Nuclear Factors to Exploit the DNA Minor Groove.
Battista S, Fedele M, Secco L, Ingo A, Sgarra R, Manfioletti G
Int J Mol Sci. 2024; 25(16).
PMID: 39201549
PMC: 11354804.
DOI: 10.3390/ijms25168863.
Decoding high mobility group A2 protein expression regulation and implications in human cancers.
Khazem F, Zetoune A
Discov Oncol. 2024; 15(1):322.
PMID: 39085703
PMC: 11291832.
DOI: 10.1007/s12672-024-01202-x.
Rare germline disorders implicate long non-coding RNAs disrupted by chromosomal structural rearrangements.
Andersen R, Alkuraya I, Ajeesh A, Sakamoto T, Mena E, Amr S
medRxiv. 2024; .
PMID: 38946951
PMC: 11213069.
DOI: 10.1101/2024.06.16.24307499.
Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome.
Maharaj A, Cottrell E, Thanasupawat T, Joustra S, Triggs-Raine B, Fujimoto M
JCI Insight. 2024; 9(6).
PMID: 38516887
PMC: 11063932.
DOI: 10.1172/jci.insight.169425.
Update on clinical characteristics and molecular insights for uterine intravenous leiomyomatosis (Review).
Zhou X, Qi X, Zhao X, Yang F
Oncol Lett. 2023; 27(1):31.
PMID: 38108079
PMC: 10722539.
DOI: 10.3892/ol.2023.14165.
Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
Ueda K, Ikeda K
Fukushima J Med Sci. 2023; 70(1):11-24.
PMID: 37952978
PMC: 10867434.
DOI: 10.5387/fms.2023-17.
Enhanced performance of gene expression predictive models with protein-mediated spatial chromatin interactions.
Chilinski M, Lipinski J, Agarwal A, Ruan Y, Plewczynski D
Sci Rep. 2023; 13(1):11693.
PMID: 37474564
PMC: 10359366.
DOI: 10.1038/s41598-023-38865-5.
Enhanced performance of gene expression predictive models with protein-mediated spatial chromatin interactions.
Chilinski M, Lipinski J, Agarwal A, Ruan Y, Plewczynski D
bioRxiv. 2023; .
PMID: 37066361
PMC: 10104055.
DOI: 10.1101/2023.04.06.535849.
Fusion of the High-mobility Group AT-Hook 2 () and the Gelsolin () Genes in Lipomas With t(9;12)(q33;q14) Chromosomal Translocation.
Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Lund-Iversen M, Micci F
In Vivo. 2023; 37(2):524-530.
PMID: 36881074
PMC: 10026638.
DOI: 10.21873/invivo.13110.
Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation.
Panagopoulos I, Heim S
Cancer Genomics Proteomics. 2022; 19(6):647-672.
PMID: 36316036
PMC: 9620447.
DOI: 10.21873/cgp.20349.
Fusion of the and Genes in Uterine Leiomyoma With t(9;12)(p22;q14).
Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S
In Vivo. 2022; 36(6):2654-2661.
PMID: 36309352
PMC: 9677776.
DOI: 10.21873/invivo.13000.
Endometrial polyps-neoplastic lesions or not? Is it time to close the files?.
Bullerdiek J, Helmke B, Laban M
Mod Pathol. 2022; 35(12):2029-2030.
PMID: 36153435
PMC: 9708551.
DOI: 10.1038/s41379-022-01162-z.
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
Kolterud A, Valimaki N, Kuisma H, Patomo J, Ilves S, Makinen N
Hum Mol Genet. 2022; 32(7):1063-1071.
PMID: 36048862
PMC: 10026225.
DOI: 10.1093/hmg/ddac217.
Stem Cell Growth and Differentiation in Organ Culture: New Insights for Uterine Fibroid Treatment.
Salas A, Beltran-Flores S, Evora C, Reyes R, Montes de Oca F, Delgado A
Biomedicines. 2022; 10(7).
PMID: 35884847
PMC: 9313456.
DOI: 10.3390/biomedicines10071542.
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.
Moison C, Spinella J, Chagraoui J, Lavallee V, Lehnertz B, Thiollier C
Blood Adv. 2022; 6(16):4793-4806.
PMID: 35797243
PMC: 9631656.
DOI: 10.1182/bloodadvances.2021005828.